EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma

Tahir Alper Cinli iD, Gökhan Burul iD, Hasan Göze iD, Mesut Ayer iD, Istemi Serin iD

Journal of Clinical Medicine · 17.06.2026 · 15 (12) · 4703

DOI: 10.3390/jcm15124703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.06.2026. Verfasst von Tahir Alper Cinli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Başakşehir Çam and Sakura City Hospital, 34480 Istanbul, Turkey. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma. Despite advances in immunochemotherapy, approximately 30–40% of patients experience relapsed or refractory disease. Nutritional and inflammatory status, reflected by composite indices, may independently influence clinical outcomes. However, the prognostic value of the Prognostic Nutritional Index (PNI), Geriatric Nutritional Risk Index (GNRI), and Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score has not been well established in DLBCL patients treated with rituximab-based regimens.

Methods

We retrospectively analyzed 192 patients with newly diagnosed DLBCL who received at least three cycles of R-CHOP or R-EPOCH at Başakşehir Çam and Sakura City Hospital between January 2020 and January 2026. Receiver operating characteristic (ROC) curve analysis was performed to determine optimal cutoff values. Kaplan–Meier analysis with log-rank testing and univariable/multivariable Cox proportional hazards regression analyses were used to evaluate the prognostic impact of the PNI, GNRI, and HALP on overall survival (OS) and progression-free survival (PFS).

Results

Among the six indices evaluated (PNI, GNRI, HALP, SII, ALI, and CAR), the PNI demonstrated the highest discriminatory ability for OS (AUC = 0.734, p = 0.001), followed by the HALP (AUC = 0.671, p = 0.020) and GNRI (AUC = 0.668, p = 0.022). The optimal cutoff values were ≤46.45 for the PNI, ≤46.91 for the GNRI, and ≤223.95 for HALP. Low values of all three indices were significantly associated with elevated LDH levels, advanced Ann Arbor stage, and higher IPI category. Kaplan–Meier analysis demonstrated significantly inferior OS in the low PNI (52.8 ± 2.6 vs. 67.1 ± 1.2 months, p = 0.001), low GNRI (49.5 ± 3.1 vs. 66.0 ± 1.4 months, p = 0.001), and low HALP (58.8 ± 2.8 vs. 64.9 ± 1.2 months, p = 0.005) groups. In separate multivariable Cox models adjusted for sex and IPI, the PNI (HR = 0.216, p = 0.009), HALP (HR = 0.276, p = 0.031), and GNRI (HR = 0.294, p = 0.011) remained independently associated with OS. No significant association was observed between these indices and PFS.

Conclusions

The PNI, GNRI, and HALP are independent prognostic markers in patients with DLBCL treated with rituximab-based regimens. These readily available and inexpensive baseline indices may complement the IPI in identifying patients at higher risk of adverse outcomes and support risk stratification at diagnosis.

Schlagwörter

Stichwörter der Autor:innen

HALP scorediffuse large B-cell lymphomageriatric nutritional risk indexoverall survivalprognosisprognostic nutritional index

Autor:innen und Institutionen

  • Department of Hematology, Başakşehir Çam and Sakura City Hospital, 34480 Istanbul, Turkey.

ORCID-Profile: Tahir Alper Cinli, Gökhan Burul, Hasan Göze, Mesut Ayer, Istemi Serin

Zitieren

APA

Cinli, T. A., Burul, G., Göze, H., Ayer, M., & Serin, I. (2026). Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma. Journal of Clinical Medicine, 15(12), 4703. https://doi.org/10.3390/jcm15124703

Vancouver

Cinli TA, Burul G, Göze H, Ayer M, Serin I. Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma. Journal of Clinical Medicine. 2026;15(12):4703. doi:10.3390/jcm15124703

BibTeX
@article{Cinli2026,
  author = {Cinli, Tahir Alper and Burul, Gökhan and Göze, Hasan and Ayer, Mesut and Serin, Istemi},
  title = {Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4703},
  doi = {10.3390/jcm15124703}
}
Kostenlos starten →